In the article “Synthetic DNA startup Catalog partners with Seagate for its DNA-based data storage platform”, TechCrunch reported that IndieBio’s Catalog (SF04 2016) is partnering with Seagate Technology to build its automated DNA-based platform for massive digital data storage and computation. In Sept. 2021, TechCrunch previously reported that Boston-based Catalog had closed a $35M series […]

IndieBio’s DNA-based data storage company Catalog (IndieBio 04) recently announced that it has encoded eight of Shakespeare’s tragedies onto strands of searchable synthetic DNA stored in a test tube, and then successfully conducted text searches of the more than 200,000 words. The Boston Globe highlighted this feat in the article, “Boston startup can search Shakespeare’s […]

Lady Technologies, Inc., the company behind kegg—a fertility tracking device that monitors cervical mucus—has secured $6.5 million in Series A led by Relentless Consumer Partners funding to advance women’s health by emphasizing the importance of cervical mucus and developing a comprehensive vaginal health platform. To date, kegg has supported 50,000 women and families on their trying-to-conceive journey. The […]

In the Sourcing Journal’s 2025 Material Innovation Report, Sabriya Stukes, partner at SOSV and chief scientific officer at IndieBio, weighs in on the growing urgency and opportunity around sustainable materials. She discusses the environmental toll of fashion, the return of VC interest in biomaterials, and why SOSV backs both new materials and the tools that […]

In a recent interview with World Textile Information Network (WTiN), SOSV General Partner Po Bronson spoke about the state of innovation in materials and textiles. See the full Q&A below: Q: In the context of the industry’s materials transition, what factors and focuses do you see as being critical over the next five years? I’ve […]

Closing out 2022, TechCrunch+ compiled the top investor perspectives of the year across various sectors from climate tech to fintech to construction tech. The year-end compilation, “The best TechCrunch+ investor surveys of 2022”, featured SOSV general partner and IndieBio CTO Pae Wu’s thoughts on the future of climate tech.  TechCrunch asked Wu two questions: Which […]

Chemical membrane company SepPure Technologies recently closed a $12M Series A with participation from Anji Microelectronics, RealTech Fund, Seeds Capital, EPS Ventures, and others.  With traditional gas-based distillation, oils are extracted and purified from their source (a seed, fiber, or other organic material) by heating the source in solvent to separate it from its remaining […]

Two Cornell-based IndieBio startups Halomine (NY 01) and Inso Biosciences (NY 03) won support from the New York State Biodefense Commercialization Fund to develop solutions that will prevent future disease outbreaks like COVID-19, the Cornell Daily Sun reported in the article “NYS Funds Cornell Startups To Combat New Disease Outbreaks”. Halomine’s primary technology, HaloFilm, extends […]

Yesterday, Trump announced a $12B critical minerals stockpile program (“Project Vault”) to procure and store critical minerals in the U.S. SOSV General Partner Duncan Turner told Bloomberg that the move signals a meaningful push to build a domestic critical-minerals supply chain – opening the door for next-gen mining, processing, and refining technologies in a sector […]

SOSV announced the close of its $306 million SOSV V fund, the firm’s largest fund to date. The news received coverage in TechCrunch, Bloomberg and Axios. The text below is from the press release SOSV issued on April 16th concerning the new fund. SOSV V will focus on deep tech startups in human and planetary health, […]